MedTech Monitor 2024
City Center
33 S. Sixth Street, Suite 3600
Minneapolis, MN 55402
Join fellow MedTech industry leaders, including CEOs, venture capitalists, in-house legal counsel and regulatory professionals, for a day-long conference on a variety of timely topics.
This can’t-miss event, co-hosted by Fox Rothschild and DuVal & Associates, P.A., will provide updates and practical takeaways.
The event opens with breakfast. A networking cocktail hour will follow the presentations.
Agenda
8 am Breakfast and registration
8:30 am Welcome Remarks
8:45 - 9:45 am Evidence Strategies Through the Lenses of FDA Appeals and Payer Needs
- Mark DuVal, CEO, DuVal & Associates
- Chris Lyle, VP Evidence Strategy, DuVal & Associates
9:45 - 10:30 am Building Relationships with VCs: Advice for Emerging Startups
- David Adair, M.D., Co-Founder & Managing Director, Solas BioVentures
- Jeff Peters, Venture Partner, OrbiMed Advisors, LLC
- Tom Moran, MedTech Partner, Fox Rothschild
- Interviewer: Kathryn Dehn, MedTech Partner, Fox Rothschild
10:30 - 10:45 am Morning Break
10:45-11:45 am Cybersecurity Updates
- Mark McCreary, Chief Artificial Intelligence & Information Security Officer, Fox Rothschild
11:45 am – Noon Lunch Break
12:00 pm – 12:45 Demystifying the TAP Advisor Role: Insights into CDRH's Total Product Life Cycle Advisory Program
- Kai Kadoich, TAP Advisor, FDA Center for Devices and Radiological Health
- Interviewer: Mark DuVal, CEO, DuVal & Associates
12:45 - 1:15 pm Key Legal Updates: Corporate Transparency Act
- JT Schuweiler, Corporate Partner, Fox Rothschild
1:15 - 1:45 pm Key Legal Updates: FTC/Noncompete Agreements
- Jenny Fuller, Employment Partner, Fox Rothschild
1:45 - 2 pm Afternoon Break
2 – 3 pm Chevron/Loper Bright and Beyond
- Bryan Feldhaus, President, DuVal & Associates
- Morgan McCall Reece, Litigation Counsel, Fox Rothschild
3 - 4 pm Current Issues and Trends in Achieving Optimal Reimbursement
- Jolayne Devers, Partner, JD Lymon Group
- Carla Monacelli, Partner, JD Lymon Group
- Mark Domyahn, Partner, JD Lymon Group
- Interviewer: Chris Lyle, VP Evidence Strategy, DuVal & Associates
4 pm Closing Remarks/Cocktail Reception

